Anti-HER3 Monoclonal Antibody LJM716

Known as: LJM716 
A human monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. Anti… (More)

Topic mentions per year

Topic mentions per year

2013-2016
012320132016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background Plasticity of the ERBB receptor network has been suggested to cause acquired resistance to anti-human epidermal growth… (More)
Is this relevant?
2017
2017
Human epidermal growth factor receptor 3 (HER3) is important in maintaining epidermal growth factor receptor-driven cancers and… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
2016
2016
Human epidermal growth factor receptor 3 (HER3) has been identified as an important component of many receptor tyrosine kinase… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Review
2016
Review
2016
UNLABELLED Emerging evidence suggests that human epidermal growth factor receptor 3 plays a critical role in cell-survival and… (More)
Is this relevant?
Review
2014
Review
2014
The HER family of receptor tyrosine kinases, including EGF receptor (EGFR), HER2, HER3, and HER4, transduce growth-promoting… (More)
Is this relevant?
2014
2014
The HER family of receptor tyrosine kinases, including EGF receptor (EGFR), HER2, HER3, and HER4, transduce growth-promoting… (More)
  • figure 1
  • figure 2
Is this relevant?
2013
2013
HER2/HER3 dimerization resulting from overexpression of HER2 or neuregulin (NRG1) in cancer leads to HER3-mediated oncogenic… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
We examined the effects of LJM716, an HER3 (ERBB3) neutralizing antibody that inhibits ligand-induced and ligand-independent HER3… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 4
Is this relevant?
2013
2013
We examined the effects of LJM716, an HER3 (ERBB3) neutralizing antibody that inhibits ligand-induced and ligand-independent HER3… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 4
Is this relevant?